Related Experiment Videos

E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest

Benjamin D Rowland1, Serguei G Denissov, Sirith Douma

  • 1Division of Molecular Carcinogenesis, Center for Biomedical Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Cancer Cell
|August 2, 2002
PubMed

Insights

E2F repressor complexes are key downstream targets of tumor suppressor pathways like p19ARF/p53. Inhibiting E2F repression prevents senescence, highlighting its role in cancer development.

Area of Science:

  • Molecular biology
  • Cellular senescence
  • Cancer research

Background:

  • The p16(INK4a)/pRB/E2F and p19(ARF)/p53 pathways are crucial tumor suppressors frequently disrupted in human cancers.
  • While p19(ARF) and p53 are known to induce senescence in mouse embryonic fibroblasts (MEFs), their downstream targets remain largely uncharacterized.

Purpose of the Study:

  • To investigate the role of E2F transcriptional repression in regulating senescence.
  • To identify downstream targets of the p19(ARF)/p53 signaling pathway.

Main Methods:

  • Studied disruption of E2F-mediated transcriptional repression in primary MEFs.
  • Analyzed the expression of E2F target genes, including p19ARF.
  • Assessed the impact of E2F repression relief on senescence induction by p19(ARF), p53, or RAS(V12).

Main Results:

  • Disruption of E2F repression led to increased expression of E2F target genes, notably p19ARF.
  • Endogenous E2F primarily functions to repress target genes in asynchronously growing MEFs.
  • Relief of E2F-mediated repression conferred resistance to senescence induced by p19(ARF), p53, or RAS(V12).

Conclusions:

  • E2F transcriptional repressor complexes are critical downstream targets of the antiproliferative p19(ARF)/p53 signaling pathway.
  • E2F-mediated repression plays a vital role in the induction of cellular senescence.

Related Concept Videos